{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:59:07Z","timestamp":1790276347702,"version":"4.1.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Stichting LSH-TKI (Healthy~Holland) under the TKI-programme Life Sciences & Health, grant number: LSHM23060."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Hepatitis B virus (HBV) drives hepatocellular carcinoma in part through the activity of its X protein (HBx), yet the mechanisms by which HBx alters hepatocyte function remain incompletely understood. Progress has been limited by the lack of relevant human models that support controlled HBx expression in mature hepatocytes. To address this limitation, here, we use an improved hepatocyte-like organoid (HLO) platform that supports enhanced hepatocyte maturation to investigate HBx function in a differentiated hepatocyte context. Adult stem cell-derived HLOs were differentiated using an optimized protocol to generate hepatocyte-like cells with enhanced maturation and transcriptional similarity to primary liver tissue. HBx function was interrogated using both cognate promoter-driven expression and doxycycline-inducible systems across multiple donor-derived organoid lines. Transcriptomic, pathway, and single-cell imaging analyses were performed to assess the impact of HBx expression on hepatocytes. HBx expression consistently suppressed apoptosis-associated transcripts and reduced expression of core hepatocyte identity genes, including CYP3A4. Pathway analysis revealed downregulation of liver-specific functions, including metabolism, detoxification, complement, and coagulation. At the single-cell level, higher HBx expression was associated with reduced caspase 3\/7 activation following apoptotic challenge and decreased hepatocyte marker expression. Functionally, the expression of HBx increased resistance to apoptosis and enhanced the ability of differentiated hepatocyte-like cells to revert to a proliferative state. HBx expression in differentiated human liver organoids reduces apoptosis and impairs hepatocyte identity, consistently across donors and expression systems. Together, these findings support a model in which HBx promotes a survival-permissive state of reduced hepatocyte differentiation. This state may contribute to early HBV-driven tumorigenesis. This HLO platform provides a relevant system to dissect HBV-host interactions and reveals a mechanism by which HBV may prime the liver for malignant transformation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact and implications<\/jats:title>\n                    <jats:p>Understanding how HBV promotes hepatocellular carcinoma remains a critical challenge, partly due to the lack of physiologically relevant human derived model systems to study HBx function. Using a differentiated adult human liver organoid system, we show that HBx simultaneously suppresses apoptosis and reduces hepatocyte differentiation, providing a mechanistic framework for how HBV may prime hepatocytes for malignant transformation. These findings are particularly relevant for researchers studying HBV pathogenesis and liver cancer, as well as for clinicians aiming to better understand early disease progression. While further validation in more complex multicellular systems is needed, this platform can support the identification of HBx-targeted therapeutic strategies and guide the development of improved adult human derived models for virus-host interaction studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41418-026-01877-5","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:54:06Z","timestamp":1790268846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis B virus protein X promotes survival and loss of hepatocyte identity in a differentiated human liver organoid system"],"prefix":"10.1038","author":[{"given":"Xingyu","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Torenvliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Galaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4765-6600","authenticated-orcid":false,"given":"Tanvir","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lincon","family":"Hasda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin E.","family":"van Royen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9165-5824","authenticated-orcid":false,"given":"Helmuth","family":"Gehart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8265-7092","authenticated-orcid":false,"given":"Eleni","family":"Katsoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung Wai","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Moulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shringar","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzin","family":"Pourfarzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2465-2081","authenticated-orcid":false,"given":"Javier Frias","family":"Aldeguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia F.","family":"Boj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5002-7728","authenticated-orcid":false,"given":"Pantelis","family":"Hatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert-Jan","family":"Palstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2060-9353","authenticated-orcid":false,"given":"Tokameh","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"1877_CR1","unstructured":"WHO. World Health Organization: WHO & World Health Organization: WHO. Hepatitis B: World Health Organization; 2025 [updated 23 July."},{"key":"1877_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1877_CR3","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.3748\/wjg.v17.i44.4853","volume":"17","author":"YJ Tan","year":"2011","unstructured":"Tan YJ. Hepatitis B virus infection and the risk of hepatocellular carcinoma. World J Gastroenterol. 2011;17:4853\u20137.","journal-title":"World J Gastroenterol"},{"key":"1877_CR4","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","volume":"64","author":"M Levrero","year":"2016","unstructured":"Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64:S84\u2013S101.","journal-title":"J Hepatol"},{"key":"1877_CR5","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3389\/fimmu.2019.02048","volume":"10","author":"Y Chen","year":"2019","unstructured":"Chen Y, Tian Z. HBV-Induced Immune Imbalance in the Development of HCC. Front Immunol. 2019;10:2048.","journal-title":"Front Immunol"},{"key":"1877_CR6","doi-asserted-by":"publisher","first-page":"12462","DOI":"10.3748\/wjg.v20.i35.12462","volume":"20","author":"M Suhail","year":"2014","unstructured":"Suhail M, Abdel-Hafiz H, Ali A, Fatima K, Damanhouri GA, Azhar E, et al. Potential mechanisms of hepatitis B virus induced liver injury. World J Gastroenterol. 2014;20:12462\u201372.","journal-title":"World J Gastroenterol"},{"key":"1877_CR7","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.1093\/cid\/ciw023","volume":"62","author":"M Dandri","year":"2016","unstructured":"Dandri M, Petersen J. Mechanism of Hepatitis B virus persistence in hepatocytes and its carcinogenic potential. Clin Infect Dis. 2016;62:S281\u20138.","journal-title":"Clin Infect Dis"},{"key":"1877_CR8","doi-asserted-by":"crossref","unstructured":"Tu T, Budzinska MA, Shackel NA, Urban S. HBV DNA integration: molecular mechanisms and clinical implications. Viruses. 2017;9:75.","DOI":"10.3390\/v9040075"},{"key":"1877_CR9","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jcmgh.2023.01.001","volume":"15","author":"SH Yeh","year":"2023","unstructured":"Yeh SH, Li CL, Lin YY, Ho MC, Wang YC, Tseng ST, et al. Hepatitis B virus DNA integration drives carcinogenesis and provides a new biomarker for HBV-related HCC. Cell Mol Gastroenterol Hepatol. 2023;15:921\u20139.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1877_CR10","doi-asserted-by":"publisher","first-page":"10238","DOI":"10.3748\/wjg.v20.i30.10238","volume":"20","author":"A Ali","year":"2014","unstructured":"Ali A, Abdel-Hafiz H, Suhail M, Al-Mars A, Zakaria MK, Fatima K, et al. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. World J Gastroenterol. 2014;20:10238\u201348.","journal-title":"World J Gastroenterol"},{"key":"1877_CR11","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2217\/14622416.8.8.997","volume":"8","author":"J Zucman-Rossi","year":"2007","unstructured":"Zucman-Rossi J, Laurent-Puig P. Genetic diversity of hepatocellular carcinomas and its potential impact on targeted therapies. Pharmacogenomics. 2007;8:997\u20131003.","journal-title":"Pharmacogenomics"},{"key":"1877_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/hep.1840090226","volume":"9","author":"RH Miller","year":"1989","unstructured":"Miller RH, Kaneko S, Chung CT, Girones R, Purcell RH. Compact organization of the hepatitis B virus genome. Hepatology. 1989;9:322\u20137.","journal-title":"Hepatology"},{"key":"1877_CR13","doi-asserted-by":"crossref","unstructured":"Li D, Hamadalnil Y, Tu T Hepatitis B viral protein HBx: roles in viral replication and hepatocarcinogenesis. Viruses. 2024;16:1361.","DOI":"10.3390\/v16091361"},{"key":"1877_CR14","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.3748\/wjg.v20.i20.6236","volume":"20","author":"H Hai","year":"2014","unstructured":"Hai H, Tamori A, Kawada N. Role of hepatitis B virus DNA integration in human hepatocarcinogenesis. World J Gastroenterol. 2014;20:6236\u201343.","journal-title":"World J Gastroenterol"},{"key":"1877_CR15","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jhep.2024.06.037","volume":"81","author":"F Zoulim","year":"2024","unstructured":"Zoulim F, Chen PJ, Dandri M, Kennedy PT, Seeger C. Hepatitis B virus DNA integration: implications for diagnostics, therapy, and outcome. J Hepatol. 2024;81:1087\u201399.","journal-title":"J Hepatol"},{"key":"1877_CR16","doi-asserted-by":"publisher","first-page":"21941","DOI":"10.1074\/jbc.M109.014563","volume":"284","author":"WK Sung","year":"2009","unstructured":"Sung WK, Lu Y, Lee CWH, Zhang D, Ronaghi M, Lee CGL. Deregulated direct targets of the hepatitis B virus (HBV) protein, HBx, identified through chromatin immunoprecipitation and expression microarray profiling. J Biol Chem. 2009;284:21941\u201354.","journal-title":"J Biol Chem"},{"key":"1877_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.724877","volume":"12","author":"E Van Damme","year":"2021","unstructured":"Van Damme E, Vanhove J, Severyn B, Verschueren L, Pauwels F. The Hepatitis B virus interactome: a comprehensive overview. Front Microbiol. 2021;12:724877.","journal-title":"Front Microbiol"},{"key":"1877_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/sj.onc.1203312","volume":"19","author":"SG Lee","year":"2000","unstructured":"Lee SG, Rho HM. Transcriptional repression of the human p53 gene by hepatitis B viral X protein. Oncogene. 2000;19:468\u201371.","journal-title":"Oncogene"},{"key":"1877_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.virusres.2010.09.023","volume":"155","author":"TL Gearhart","year":"2011","unstructured":"Gearhart TL, Bouchard MJ. The hepatitis B virus HBx protein modulates cell cycle regulatory proteins in cultured primary human hepatocytes. Virus Res. 2011;155:363\u20137.","journal-title":"Virus Res"},{"key":"1877_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jhep.2021.08.010","volume":"76","author":"K Sekiba","year":"2022","unstructured":"Sekiba K, Otsuka M, Funato K, Miyakawa Y, Tanaka E, Seimiya T, et al. HBx-induced degradation of Smc5\/6 complex impairs homologous recombination-mediated repair of damaged DNA. J Hepatol. 2022;76:53\u201362.","journal-title":"J Hepatol"},{"key":"1877_CR21","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/hep.27360","volume":"61","author":"BL Slagle","year":"2015","unstructured":"Slagle BL, Andrisani OM, Bouchard MJ, Lee CG, Ou JH, Siddiqui A. Technical standards for hepatitis B virus X protein (HBx) research. Hepatology. 2015;61:1416\u201324.","journal-title":"Hepatology"},{"key":"1877_CR22","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.3748\/wjg.v12.i29.4673","volume":"12","author":"N Fiedler","year":"2006","unstructured":"Fiedler N, Quant E, Fink L, Sun J, Schuster R, Gerlich WH, et al. Differential effects on apoptosis induction in hepatocyte lines by stable expression of hepatitis B virus X protein. World J Gastroenterol. 2006;12:4673\u201382.","journal-title":"World J Gastroenterol"},{"key":"1877_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jprot.2016.01.016","volume":"136","author":"JR Wisniewski","year":"2016","unstructured":"Wisniewski JR, Vildhede A, Noren A, Artursson P. In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes. J Proteom. 2016;136:234\u201347.","journal-title":"J Proteom"},{"key":"1877_CR24","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1093\/nar\/gkz169","volume":"47","author":"B Zhou","year":"2019","unstructured":"Zhou B, Ho SS, Greer SU, Spies N, Bell JM, Zhang X, et al. Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2. Nucleic Acids Res. 2019;47:3846\u201361.","journal-title":"Nucleic Acids Res"},{"key":"1877_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00204-016-1694-y","volume":"91","author":"JA Heslop","year":"2017","unstructured":"Heslop JA, Rowe C, Walsh J, Sison-Young R, Jenkins R, Kamalian L, et al. Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile. Arch Toxicol. 2017;91:439\u201352.","journal-title":"Arch Toxicol"},{"key":"1877_CR26","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1073\/pnas.1919035117","volume":"117","author":"E Michailidis","year":"2020","unstructured":"Michailidis E, Vercauteren K, Mancio-Silva L, Andrus L, Jahan C, Ricardo-Lax I, et al. Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytes. Proc Natl Acad Sci USA. 2020;117:1678\u201388.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1877_CR27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jhep.2014.10.016","volume":"62","author":"M Baxter","year":"2015","unstructured":"Baxter M, Withey S, Harrison S, Segeritz CP, Zhang F, Atkinson-Dell R, et al. Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes. J Hepatol. 2015;62:581\u20139.","journal-title":"J Hepatol"},{"key":"1877_CR28","doi-asserted-by":"crossref","unstructured":"Panchuk I, Kovalskaia V, Kochergin-Nikitsky K, Yakushina V, Balinova N, Ryzhkova O, et al. Transcriptomic profile of directed differentiation of iPSCs into hepatocyte-like cells. Int J Mol Sci. 2026;27:633.","DOI":"10.3390\/ijms27020633"},{"key":"1877_CR29","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172:2731\u20138.","journal-title":"J Immunol"},{"key":"1877_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","volume":"160","author":"M Huch","year":"2015","unstructured":"Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen MM, et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell. 2015;160:299\u2013312.","journal-title":"Cell"},{"key":"1877_CR31","doi-asserted-by":"crossref","unstructured":"De Crignis E, Hossain T, Romal S, Carofiglio F, Moulos P, Khalid MM, et al. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma. Elife. 2021;10:e60747.","DOI":"10.7554\/eLife.60747"},{"key":"1877_CR32","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4358","volume":"12","author":"S Romal","year":"2022","unstructured":"Romal S, Hossain T, Mahmoudi T. Generation, maintenance and HBV infection of human liver organoids. Bio Protoc. 2022;12:e4358.","journal-title":"Bio Protoc"},{"key":"1877_CR33","unstructured":"Clevers H, Gehart H, inventors. Improved differentiation method. International patent WO 2017\/149025 A1. 2017."},{"key":"1877_CR34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/ncb3349","volume":"18","author":"W Birchmeier","year":"2016","unstructured":"Birchmeier W. Orchestrating Wnt signalling for metabolic liver zonation. Nat Cell Biol. 2016;18:463\u20135.","journal-title":"Nat Cell Biol"},{"key":"1877_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41575-018-0075-9","volume":"16","author":"MJ Perugorria","year":"2019","unstructured":"Perugorria MJ, Olaizola P, Labiano I, Esparza-Baquer A, Marzioni M, Marin JJG, et al. Wnt-beta-catenin signalling in liver development, health and disease. Nat Rev Gastroenterol Hepatol. 2019;16:121\u201336.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1877_CR36","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.immuni.2025.04.002","volume":"58","author":"NF Modares","year":"2025","unstructured":"Modares NF, Hendrikse LD, Smith LK, Paul MS, Haight J, Luo P, et al. B cell-derived acetylcholine promotes liver regeneration by regulating Kupffer cell and hepatic CD8(+) T cell function. Immunity. 2025;58:1201\u201316.e7.","journal-title":"Immunity"},{"key":"1877_CR37","doi-asserted-by":"publisher","first-page":"e3002728","DOI":"10.1371\/journal.pbio.3002728","volume":"22","author":"H Jun","year":"2024","unstructured":"Jun H, Liu S, Knights AJ, Zhu K, Ma Y, Gong J, et al. Signaling through the nicotinic acetylcholine receptor in the liver protects against the development of metabolic dysfunction-associated steatohepatitis. PLoS Biol. 2024;22:e3002728.","journal-title":"PLoS Biol"},{"key":"1877_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06318-7","volume":"9","author":"SA MacParland","year":"2018","unstructured":"MacParland SA, Liu JC, Ma XZ, Innes BT, Bartczak AM, Gage BK, et al. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat Commun. 2018;9:4383.","journal-title":"Nat Commun"},{"key":"1877_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/j.2040-4603.2014.tb00548.x","volume":"4","author":"L Rui","year":"2014","unstructured":"Rui L. Energy metabolism in the liver. Compr Physiol. 2014;4:177\u201397.","journal-title":"Compr Physiol"},{"key":"1877_CR40","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/j.thromres.2014.03.023","volume":"133","author":"AK Kopec","year":"2014","unstructured":"Kopec AK, Luyendyk JP. Coagulation in liver toxicity and disease: role of hepatocyte tissue factor. Thromb Res. 2014;133:S57\u20139.","journal-title":"Thromb Res"},{"key":"1877_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2019.100017","volume":"2","author":"T Lung","year":"2019","unstructured":"Lung T, Sakem B, Risch L, Wurzner R, Colucci G, Cerny A, et al. The complement system in liver diseases: Evidence-based approach and therapeutic options. J Transl Autoimmun. 2019;2:100017.","journal-title":"J Transl Autoimmun"},{"key":"1877_CR42","unstructured":"Kalra A, Yetiskul E, Wehrle CJ, Tuma F Physiology, Liver. StatPearls. Treasure Island (FL)2026."},{"key":"1877_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.14044","volume":"32","author":"X Tan","year":"2025","unstructured":"Tan X, Xun L, Yin Q, Chen C, Zhang T, Shen T. Epigenetic Modifications in HBV-Related Hepatocellular Carcinoma. J Viral Hepat. 2025;32:e14044.","journal-title":"J Viral Hepat"},{"key":"1877_CR44","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods. 2013;10:1213\u20138.","journal-title":"Nat Methods"},{"key":"1877_CR45","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.1630","volume":"28","author":"CY McLean","year":"2010","unstructured":"McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol. 2010;28:495\u2013501.","journal-title":"Nat Biotechnol"},{"key":"1877_CR46","doi-asserted-by":"publisher","first-page":"D726","DOI":"10.1093\/nar\/gkv1160","volume":"44","author":"CA Sloan","year":"2016","unstructured":"Sloan CA, Chan ET, Davidson JM, Malladi VS, Strattan JS, Hitz BC, et al. ENCODE data at the ENCODE portal. Nucleic Acids Res. 2016;44:D726\u201332.","journal-title":"Nucleic Acids Res"},{"key":"1877_CR47","doi-asserted-by":"publisher","first-page":"23996","DOI":"10.18632\/oncotarget.15098","volume":"8","author":"P Li","year":"2017","unstructured":"Li P, Zhou L, Zhao T, Liu X, Zhang P, Liu Y, et al. Caspase-9: structure, mechanisms and clinical application. Oncotarget. 2017;8:23996\u20134008.","journal-title":"Oncotarget"},{"key":"1877_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-14-32","volume":"14","author":"M Brentnall","year":"2013","unstructured":"Brentnall M, Rodriguez-Menocal L, De Guevara RL, Cepero E, Boise LH. Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol. 2013;14:32.","journal-title":"BMC Cell Biol"},{"key":"1877_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1126\/science.1076807","volume":"299","author":"X Jiang","year":"2003","unstructured":"Jiang X, Kim HE, Shu H, Zhao Y, Zhang H, Kofron J, et al. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science. 2003;299:223\u20136.","journal-title":"Science"},{"key":"1877_CR50","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0008-6363(99)00384-3","volume":"45","author":"A Saraste","year":"2000","unstructured":"Saraste A. Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. 2000;45:528\u201337.","journal-title":"Cardiovasc Res"},{"key":"1877_CR51","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41416-022-02020-0","volume":"128","author":"C Nossing","year":"2023","unstructured":"Nossing C, Ryan KM. 50 years on and still very much alive: \u2018Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 2023;128:426\u201331.","journal-title":"Br J Cancer"},{"key":"1877_CR52","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35:495\u2013516.","journal-title":"Toxicol Pathol"},{"key":"1877_CR53","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2174\/138920007779815986","volume":"8","author":"CP Martinez-Jimenez","year":"2007","unstructured":"Martinez-Jimenez CP, Jover R, Donato MT, Castell JV, Gomez-Lechon MJ. Transcriptional regulation and expression of CYP3A4 in hepatocytes. Curr Drug Metab. 2007;8:185\u201394.","journal-title":"Curr Drug Metab"},{"key":"1877_CR54","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.ajpath.2018.03.008","volume":"188","author":"H Gilgenkrantz","year":"2018","unstructured":"Gilgenkrantz H, Collin de l\u2019Hortet A. Understanding liver regeneration: from mechanisms to regenerative medicine. Am J Pathol. 2018;188:1316\u201327.","journal-title":"Am J Pathol"},{"key":"1877_CR55","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v17.i7.107378","volume":"17","author":"B Korchilava","year":"2025","unstructured":"Korchilava B, Khachidze T, Megrelishvili N, Svanadze L, Kakabadze M, Tsomaia K, et al. Liver regeneration after partial hepatectomy: Triggers and mechanisms. World J Hepatol. 2025;17:107378.","journal-title":"World J Hepatol"},{"key":"1877_CR56","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.stem.2014.09.008","volume":"15","author":"BD Tarlow","year":"2014","unstructured":"Tarlow BD, Pelz C, Naugler WE, Wakefield L, Wilson EM, Finegold MJ, et al. Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Cell Stem Cell. 2014;15:605\u201318.","journal-title":"Cell Stem Cell"},{"key":"1877_CR57","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/hep.24712","volume":"55","author":"Y Chen","year":"2012","unstructured":"Chen Y, Wong PP, Sjeklocha L, Steer CJ, Sahin MB. Mature hepatocytes exhibit unexpected plasticity by direct dedifferentiation into liver progenitor cells in culture. Hepatology. 2012;55:563\u201374.","journal-title":"Hepatology"},{"key":"1877_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57\u201370.","journal-title":"Cell"},{"key":"1877_CR59","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"1877_CR60","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41579-018-0064-6","volume":"16","author":"NA Krump","year":"2018","unstructured":"Krump NA, You J. Molecular mechanisms of viral oncogenesis in humans. Nat Rev Microbiol. 2018;16:684\u201398.","journal-title":"Nat Rev Microbiol"},{"key":"1877_CR61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/hep.31231","volume":"73","author":"KM Sze","year":"2021","unstructured":"Sze KM, Ho DW, Chiu YT, Tsui YM, Chan LK, Lee JM, et al. Hepatitis B virus-telomerase reverse transcriptase promoter integration harnesses host ELF4, resulting in telomerase reverse transcriptase gene transcription in hepatocellular carcinoma. Hepatology. 2021;73:23\u201340.","journal-title":"Hepatology"},{"key":"1877_CR62","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.1038\/s41388-019-0872-9","volume":"38","author":"X Yuan","year":"2019","unstructured":"Yuan X, Larsson C, Xu D. Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players. Oncogene. 2019;38:6172\u201383.","journal-title":"Oncogene"},{"key":"1877_CR63","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2005.05.014","volume":"236","author":"J Miao","year":"2006","unstructured":"Miao J, Chen GG, Chun SY, Lai PP. Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression. Cancer Lett. 2006;236:115\u201324.","journal-title":"Cancer Lett"},{"key":"1877_CR64","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11596-007-0215-x","volume":"27","author":"L Ye","year":"2007","unstructured":"Ye L, Qi J, Li G, Tao D, Song S. The effect of HBx gene on the apoptosis of hepatic cells. J Huazhong Univ Sci Technol Med Sci. 2007;27:167\u20139.","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"1877_CR65","doi-asserted-by":"publisher","first-page":"8744","DOI":"10.1073\/pnas.94.16.8744","volume":"94","author":"F Su","year":"1997","unstructured":"Su F, Schneider RJ. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci USA. 1997;94:8744\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1877_CR66","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1093\/emboj\/cdg210","volume":"22","author":"KH Kim","year":"2003","unstructured":"Kim KH, Seong BL. Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal. EMBO J. 2003;22:2104\u201316.","journal-title":"EMBO J"},{"key":"1877_CR67","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12985-015-0416-z","volume":"12","author":"F Kong","year":"2015","unstructured":"Kong F, You H, Zhao J, Liu W, Hu L, Luo W, et al. The enhanced expression of death receptor 5 (DR5) mediated by HBV X protein through NF-kappaB pathway is associated with cell apoptosis induced by (TNF-alpha related apoptosis inducing ligand) TRAIL in hepatoma cells. Virol J. 2015;12:192.","journal-title":"Virol J"},{"key":"1877_CR68","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0753-3322(99)80003-1","volume":"52","author":"T Pollicino","year":"1998","unstructured":"Pollicino T, Terradillos O, Lecoeur H, Gougeon ML, Buendia MA. Pro-apoptotic effect of the hepatitis B virus X gene. Biomed Pharmacother. 1998;52:363\u20138.","journal-title":"Biomed Pharmacother"},{"key":"1877_CR69","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1099\/0022-1317-82-1-171","volume":"82","author":"J Pan","year":"2001","unstructured":"Pan J, Duan LX, Sun BS, Feitelson MA. Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa. B J Gen Virol. 2001;82:171\u201382.","journal-title":"B J Gen Virol"},{"key":"1877_CR70","doi-asserted-by":"publisher","first-page":"16969","DOI":"10.1074\/jbc.M011263200","volume":"276","author":"YI Lee","year":"2001","unstructured":"Lee YI, Kang-Park S, Do SI, Lee YI. The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem. 2001;276:16969\u201377.","journal-title":"J Biol Chem"},{"key":"1877_CR71","doi-asserted-by":"publisher","first-page":"25858","DOI":"10.1074\/jbc.M003578200","volume":"275","author":"WL Shih","year":"2000","unstructured":"Shih WL, Kuo ML, Chuang SE, Cheng AL, Doong SL. Hepatitis B virus X protein inhibits transforming growth factor-beta -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem. 2000;275:25858\u201364.","journal-title":"J Biol Chem"},{"key":"1877_CR72","doi-asserted-by":"publisher","first-page":"8328","DOI":"10.1074\/jbc.M006026200","volume":"276","author":"J Diao","year":"2001","unstructured":"Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, et al. X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK\/JNK pathway. J Biol Chem. 2001;276:8328\u201340.","journal-title":"J Biol Chem"},{"key":"1877_CR73","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1128\/JVI.02440-14","volume":"89","author":"S Rawat","year":"2015","unstructured":"Rawat S, Bouchard MJ. The hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival. J Virol. 2015;89:999\u20131012.","journal-title":"J Virol"},{"key":"1877_CR74","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.gene.2018.12.054","volume":"691","author":"X Wang","year":"2019","unstructured":"Wang X, Huo B, Liu J, Huang X, Zhang S, Feng T. Hepatitis B virus X reduces hepatocyte apoptosis and promotes cell cycle progression through the Akt\/mTOR pathway in vivo. Gene. 2019;691:87\u201395.","journal-title":"Gene"},{"key":"1877_CR75","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11010-013-1769-5","volume":"383","author":"L Shen","year":"2013","unstructured":"Shen L, Zhang X, Hu D, Feng T, Li H, Lu Y, et al. Hepatitis B virus X (HBx) play an anti-apoptosis role in hepatic progenitor cells by activating Wnt\/beta-catenin pathway. Mol Cell Biochem. 2013;383:213\u201322.","journal-title":"Mol Cell Biochem"},{"key":"1877_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/srep24430","volume":"6","author":"Y Dan","year":"2016","unstructured":"Dan Y, Zhang Y, Cheng L, Ma J, Xi Y, Yang L, et al. Hepatitis B virus X protein (HBx)-induced abnormalities of nucleic acid metabolism revealed by (1)H-NMR-based metabonomics. Sci Rep. 2016;6:24430.","journal-title":"Sci Rep"},{"key":"1877_CR77","doi-asserted-by":"publisher","first-page":"29872","DOI":"10.1074\/jbc.M111.259978","volume":"286","author":"HJ Shin","year":"2011","unstructured":"Shin HJ, Park YH, Kim SU, Moon HB, Park DS, Han YH, et al. Hepatitis B virus X protein regulates hepatic glucose homeostasis via activation of inducible nitric oxide synthase. J Biol Chem. 2011;286:29872\u201381.","journal-title":"J Biol Chem"},{"key":"1877_CR78","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1089\/cell.2023.0055","volume":"25","author":"MG Sanal","year":"2023","unstructured":"Sanal MG, Gupta S, Saha R, Vats N, Sarin SK. Hepatitis B Virus x Protein Increases Cellular OCT3\/4 and MYC and Facilitates Cellular Reprogramming. Cell Reprogram. 2023;25:224\u201337.","journal-title":"Cell Reprogram"},{"key":"1877_CR79","doi-asserted-by":"publisher","first-page":"e107913","DOI":"10.1371\/journal.pone.0107913","volume":"9","author":"H Liu","year":"2014","unstructured":"Liu H, Lou G, Li C, Wang X, Cederbaum AI, Gan L, et al. HBx inhibits CYP2E1 gene expression via downregulating HNF4alpha in human hepatoma cells. PLoS One. 2014;9:e107913.","journal-title":"PLoS One"},{"key":"1877_CR80","doi-asserted-by":"crossref","unstructured":"Park S, Ha YN, Dezhbord M, Lee AR, Park ES, Park YK, et al. Suppression of hepatocyte nuclear factor 4 alpha by long-term infection of Hepatitis B virus contributes to tumor cell proliferation. Int J Mol Sci. 2020;21:948.","DOI":"10.3390\/ijms21030948"},{"key":"1877_CR81","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nm815","volume":"9","author":"RG Tirona","year":"2003","unstructured":"Tirona RG, Lee W, Leake BF, Lan LB, Cline CB, Lamba V, et al. The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med. 2003;9:220\u20134.","journal-title":"Nat Med"},{"key":"1877_CR82","first-page":"466","volume":"9","author":"Y Niu","year":"2021","unstructured":"Niu Y, Fan S, Luo Q, Chen L, Huang D, Chang W, et al. Interaction of Hepatitis B virus X protein with the pregnane X receptor enhances the synergistic effects of aflatoxin B1 and Hepatitis B virus on promoting hepatocarcinogenesis. J Clin Transl Hepatol. 2021;9:466\u201376.","journal-title":"J Clin Transl Hepatol"},{"key":"1877_CR83","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.dld.2013.06.004","volume":"45","author":"Y Niu","year":"2013","unstructured":"Niu Y, Wu Z, Shen Q, Song J, Luo Q, You H, et al. Hepatitis B virus X protein co-activates pregnane X receptor to induce the cytochrome P450 3A4 enzyme, a potential implication in hepatocarcinogenesis. Dig Liver Dis. 2013;45:1041\u20138.","journal-title":"Dig Liver Dis"},{"key":"1877_CR84","doi-asserted-by":"publisher","first-page":"96027","DOI":"10.18632\/oncotarget.21630","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, He J, Fu Y, Hu X, Sun LQ, Huang Y, et al. Hepatitis B virus X protein inhibits apoptosis by modulating endoplasmic reticulum stress response. Oncotarget. 2017;8:96027\u201334.","journal-title":"Oncotarget"},{"key":"1877_CR85","doi-asserted-by":"publisher","first-page":"12725","DOI":"10.1128\/JVI.78.23.12725-12734.2004","volume":"78","author":"MJ Bouchard","year":"2004","unstructured":"Bouchard MJ, Schneider RJ. The enigmatic X gene of hepatitis B virus. J Virol. 2004;78:12725\u201334.","journal-title":"J Virol"},{"key":"1877_CR86","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1002\/j.1460-2075.1995.tb00156.x","volume":"14","author":"M Doria","year":"1995","unstructured":"Doria M, Klein N, Lucito R, Schneider RJ. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J. 1995;14:4747\u201357.","journal-title":"EMBO J"},{"key":"1877_CR87","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1099\/0022-1317-82-4-871","volume":"82","author":"F Henkler","year":"2001","unstructured":"Henkler F, Hoare J, Waseem N, Goldin RD, McGarvey MJ, Koshy R, et al. Intracellular localization of the hepatitis B virus HBx protein. J Gen Virol. 2001;82:871\u201382.","journal-title":"J Gen Virol"},{"key":"1877_CR88","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/abbs\/gmr048","volume":"43","author":"J Ma","year":"2011","unstructured":"Ma J, Sun T, Park S, Shen G, Liu J. The role of hepatitis B virus X protein is related to its differential intracellular localization. Acta Biochim Biophys Sin (Shanghai). 2011;43:583\u20138.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"1877_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2026.110931","volume":"621","author":"Y Ariumi","year":"2026","unstructured":"Ariumi Y. Novel HBx-interacting host cellular factors regulate dynamic nuclear and cytoplasmic localization of Hepatitis B virus X protein (HBx). Virology. 2026;621:110931.","journal-title":"Virology"},{"key":"1877_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2025.100887","volume":"5","author":"P Llorens-Giralt","year":"2025","unstructured":"Llorens-Giralt P, Ruiz-Romero M, Nurtdinov R, Herranz-Iturbide M, Vicent GP, Serras F, et al. Sequential activation of transcription factors promotes liver regeneration through specific and developmental enhancers. Cell Genom. 2025;5:100887.","journal-title":"Cell Genom"},{"key":"1877_CR91","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.biochi.2003.09.006","volume":"85","author":"M Ameyar","year":"2003","unstructured":"Ameyar M, Wisniewska M, Weitzman JB. A role for AP-1 in apoptosis: the case for and against. Biochimie. 2003;85:747\u201352.","journal-title":"Biochimie"},{"key":"1877_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.636568","volume":"12","author":"K Dhatchinamoorthy","year":"2021","unstructured":"Dhatchinamoorthy K, Colbert JD, Rock KL. Cancer immune evasion through loss of MHC class I antigen presentation. Front Immunol. 2021;12:636568.","journal-title":"Front Immunol"},{"key":"1877_CR93","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1038\/s41388-025-03625-4","volume":"44","author":"W Chen","year":"2025","unstructured":"Chen W, Lin C, Wang L, Yu Z, Xu Y, Zhang M, et al. Hepatitis B virus X protein promotes the progression and immune escape of hepatocellular carcinoma by activating KLF16-C12orf49-PD-L1 axis. Oncogene. 2025;44:4747\u201362.","journal-title":"Oncogene"},{"key":"1877_CR94","doi-asserted-by":"publisher","first-page":"e0325363","DOI":"10.1371\/journal.pone.0325363","volume":"20","author":"J Zhong","year":"2025","unstructured":"Zhong J, Li Y, Liu Y, Qiao J, Wu Y, Kong X, et al. Hepatitis B virus X protein (HBx)-mediated immune modulation and prognostic model development in hepatocellular carcinoma. PLoS One. 2025;20:e0325363.","journal-title":"PLoS One"},{"key":"1877_CR95","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/00042737-200107000-00004","volume":"13","author":"G Ramadori","year":"2001","unstructured":"Ramadori G, Armbrust T. Cytokines in the liver. Eur J Gastroenterol Hepatol. 2001;13:777\u201384.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1877_CR96","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1600-0676.1989.tb00372.x","volume":"9","author":"K Yoshioka","year":"1989","unstructured":"Yoshioka K, Kakumu S, Tahara H, Arao M, Fuji A. Effect of interferon alpha, gamma, and tumor necrosis factor alpha on the HLA-A, B, C expression of cell lines derived from human liver. Liver. 1989;9:14\u20139.","journal-title":"Liver"},{"key":"1877_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emm.1998.1","volume":"30","author":"A Raval","year":"1998","unstructured":"Raval A, Puri N, Rath PC, Saxena RK. Cytokine regulation of expression of class I MHC antigens. Exp Mol Med. 1998;30:1\u201313.","journal-title":"Exp Mol Med"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01877-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01877-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01877-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:02:35Z","timestamp":1790272955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01877-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":97,"alternative-id":["1877"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01877-5","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"14 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}